vs
ORTHOPEDIATRICS CORP（KIDS）与RE/MAX Holdings, Inc.（RMAX）财务数据对比。点击上方公司名可切换其他公司
RE/MAX Holdings, Inc.的季度营收约是ORTHOPEDIATRICS CORP的1.2倍（$71.1M vs $61.6M），RE/MAX Holdings, Inc.净利率更高（2.0% vs -16.4%，领先18.4%），ORTHOPEDIATRICS CORP同比增速更快（17.0% vs -1.8%），RE/MAX Holdings, Inc.自由现金流更多（$33.5M vs $9.7M），过去两年ORTHOPEDIATRICS CORP的营收复合增速更高（17.4% vs -4.7%）
OrthoPediatrics是一家美国生物科技企业，总部位于印第安纳州华沙，专注于设计、研发、生产并分销用于儿科诊疗的骨科植入物与手术器械。
RE/MAX是全球知名的房地产特许经营机构，业务遍布全球一百多个国家和地区，旗下拥有数千家门店，总计超过十万名房产经纪人，在国际房产中介领域拥有极高的品牌知名度与市场影响力。
KIDS vs RMAX — 直观对比
营收规模更大
RMAX
是对方的1.2倍
$61.6M
营收增速更快
KIDS
高出18.8%
-1.8%
净利率更高
RMAX
高出18.4%
-16.4%
自由现金流更多
RMAX
多$23.8M
$9.7M
两年增速更快
KIDS
近两年复合增速
-4.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $61.6M | $71.1M |
| 净利润 | $-10.1M | $1.4M |
| 毛利率 | 73.2% | — |
| 营业利润率 | -13.3% | 13.1% |
| 净利率 | -16.4% | 2.0% |
| 营收同比 | 17.0% | -1.8% |
| 净利润同比 | 37.1% | -75.2% |
| 每股收益（稀释后） | $-0.43 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KIDSRMAX
| Q4 25 | $61.6M | $71.1M | ||
| Q3 25 | $61.3M | $73.2M | ||
| Q2 25 | $61.1M | $72.8M | ||
| Q1 25 | $52.4M | $74.5M | ||
| Q4 24 | $52.7M | $72.5M | ||
| Q3 24 | $54.6M | $78.5M | ||
| Q2 24 | $52.8M | $78.5M | ||
| Q1 24 | $44.7M | $78.3M |
净利润KIDSRMAX
| Q4 25 | $-10.1M | $1.4M | ||
| Q3 25 | $-11.8M | $4.0M | ||
| Q2 25 | $-7.1M | $4.7M | ||
| Q1 25 | $-10.7M | $-2.0M | ||
| Q4 24 | $-16.1M | $5.8M | ||
| Q3 24 | $-7.9M | $966.0K | ||
| Q2 24 | $-6.0M | $3.7M | ||
| Q1 24 | $-7.8M | $-3.4M |
毛利率KIDSRMAX
| Q4 25 | 73.2% | — | ||
| Q3 25 | 73.9% | — | ||
| Q2 25 | 72.1% | — | ||
| Q1 25 | 73.0% | — | ||
| Q4 24 | 67.5% | — | ||
| Q3 24 | 73.4% | — | ||
| Q2 24 | 77.3% | — | ||
| Q1 24 | 72.0% | — |
营业利润率KIDSRMAX
| Q4 25 | -13.3% | 13.1% | ||
| Q3 25 | -15.4% | 25.0% | ||
| Q2 25 | -17.4% | 19.3% | ||
| Q1 25 | -21.0% | 7.2% | ||
| Q4 24 | -26.7% | 5.9% | ||
| Q3 24 | -10.2% | 19.4% | ||
| Q2 24 | -10.7% | 20.6% | ||
| Q1 24 | -21.8% | 5.8% |
净利率KIDSRMAX
| Q4 25 | -16.4% | 2.0% | ||
| Q3 25 | -19.2% | 5.4% | ||
| Q2 25 | -11.6% | 6.4% | ||
| Q1 25 | -20.3% | -2.6% | ||
| Q4 24 | -30.5% | 8.0% | ||
| Q3 24 | -14.5% | 1.2% | ||
| Q2 24 | -11.4% | 4.7% | ||
| Q1 24 | -17.5% | -4.3% |
每股收益（稀释后）KIDSRMAX
| Q4 25 | $-0.43 | — | ||
| Q3 25 | $-0.50 | — | ||
| Q2 25 | $-0.30 | — | ||
| Q1 25 | $-0.46 | — | ||
| Q4 24 | $-0.70 | — | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-0.26 | — | ||
| Q1 24 | $-0.34 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $60.9M | $118.7M |
| 总债务越低越好 | $106.0M | $432.2M |
| 股东权益账面价值 | $346.6M | $452.4M |
| 总资产 | $508.6M | $582.5M |
| 负债/权益比越低杠杆越低 | 0.31× | 0.96× |
8季度趋势，按日历期对齐
现金及短期投资KIDSRMAX
| Q4 25 | $60.9M | $118.7M | ||
| Q3 25 | $57.7M | $107.5M | ||
| Q2 25 | $70.1M | $94.3M | ||
| Q1 25 | $58.8M | $89.1M | ||
| Q4 24 | $68.8M | $96.6M | ||
| Q3 24 | $76.1M | $83.8M | ||
| Q2 24 | $28.9M | $66.1M | ||
| Q1 24 | $47.7M | $82.1M |
总债务KIDSRMAX
| Q4 25 | $106.0M | $432.2M | ||
| Q3 25 | $105.3M | $433.3M | ||
| Q2 25 | $102.7M | $434.4M | ||
| Q1 25 | $77.4M | $435.3M | ||
| Q4 24 | $77.5M | $436.2M | ||
| Q3 24 | $76.9M | $437.2M | ||
| Q2 24 | $11.2M | $438.1M | ||
| Q1 24 | $11.3M | $439.0M |
股东权益KIDSRMAX
| Q4 25 | $346.6M | $452.4M | ||
| Q3 25 | $349.3M | $448.1M | ||
| Q2 25 | $355.5M | $442.4M | ||
| Q1 25 | $347.1M | $433.5M | ||
| Q4 24 | $354.6M | $429.5M | ||
| Q3 24 | $370.9M | $423.1M | ||
| Q2 24 | $371.3M | $418.4M | ||
| Q1 24 | $370.6M | $412.0M |
总资产KIDSRMAX
| Q4 25 | $508.6M | $582.5M | ||
| Q3 25 | $493.5M | $582.2M | ||
| Q2 25 | $503.6M | $574.8M | ||
| Q1 25 | $470.3M | $571.4M | ||
| Q4 24 | $473.2M | $581.6M | ||
| Q3 24 | $489.3M | $578.6M | ||
| Q2 24 | $430.8M | $571.4M | ||
| Q1 24 | $437.2M | $566.7M |
负债/权益比KIDSRMAX
| Q4 25 | 0.31× | 0.96× | ||
| Q3 25 | 0.30× | 0.97× | ||
| Q2 25 | 0.29× | 0.98× | ||
| Q1 25 | 0.22× | 1.00× | ||
| Q4 24 | 0.22× | 1.02× | ||
| Q3 24 | 0.21× | 1.03× | ||
| Q2 24 | 0.03× | 1.05× | ||
| Q1 24 | 0.03× | 1.07× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $10.3M | $40.9M |
| 自由现金流经营现金流 - 资本支出 | $9.7M | $33.5M |
| 自由现金流率自由现金流/营收 | 15.8% | 47.1% |
| 资本支出强度资本支出/营收 | 1.0% | 10.4% |
| 现金转化率经营现金流/净利润 | — | 28.39× |
| 过去12个月自由现金流最近4个季度 | $-16.0M | $56.8M |
8季度趋势，按日历期对齐
经营现金流KIDSRMAX
| Q4 25 | $10.3M | $40.9M | ||
| Q3 25 | $-581.0K | $17.7M | ||
| Q2 25 | $-10.5M | $4.6M | ||
| Q1 25 | $-4.2M | $5.7M | ||
| Q4 24 | $-4.0M | $59.7M | ||
| Q3 24 | $-10.3M | $17.6M | ||
| Q2 24 | $-6.1M | $15.9M | ||
| Q1 24 | $-6.7M | $9.4M |
自由现金流KIDSRMAX
| Q4 25 | $9.7M | $33.5M | ||
| Q3 25 | $-3.4M | $16.4M | ||
| Q2 25 | $-13.9M | $2.9M | ||
| Q1 25 | $-8.4M | $4.0M | ||
| Q4 24 | $-4.2M | $53.0M | ||
| Q3 24 | $-11.7M | $16.3M | ||
| Q2 24 | $-12.8M | $14.0M | ||
| Q1 24 | $-13.2M | $6.8M |
自由现金流率KIDSRMAX
| Q4 25 | 15.8% | 47.1% | ||
| Q3 25 | -5.6% | 22.4% | ||
| Q2 25 | -22.8% | 4.0% | ||
| Q1 25 | -16.0% | 5.3% | ||
| Q4 24 | -8.1% | 73.2% | ||
| Q3 24 | -21.4% | 20.8% | ||
| Q2 24 | -24.2% | 17.8% | ||
| Q1 24 | -29.4% | 8.6% |
资本支出强度KIDSRMAX
| Q4 25 | 1.0% | 10.4% | ||
| Q3 25 | 4.6% | 1.8% | ||
| Q2 25 | 5.6% | 2.2% | ||
| Q1 25 | 8.1% | 2.3% | ||
| Q4 24 | 0.5% | 9.1% | ||
| Q3 24 | 2.5% | 1.7% | ||
| Q2 24 | 12.7% | 2.4% | ||
| Q1 24 | 14.5% | 3.3% |
现金转化率KIDSRMAX
| Q4 25 | — | 28.39× | ||
| Q3 25 | — | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 10.28× | ||
| Q3 24 | — | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KIDS
暂无分部数据
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
